Neuroprotective and Anti-nociceptive Potential of Ambroxol in Oxaliplatin Induced Peripheral Neuropathic Pain in Rats

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biology and medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/0974-8369.1000268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy.

  2012cited by this paper
• Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin.

  2012cited by this paper
• Corrigendum to “Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain” [Eur. J. Pharmacol. 668 (2011) 155–162]

  2011cited by this paper
• Lacosamide has protective disease modifying properties in experimental vincristine neuropathy.

  2011cited by this paper
• Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

  2011cited by this paper
• Antinociceptive effect of ambroxol in rats with neuropathic spinal cord injury pain.

  2010cited by this paper
• [Chemotherapy-induced peripheral neuropathy: an unresolved issue].

  2010cited by this paper
• Supraspinal role of protein kinase C in oxaliplatin‐induced neuropathy in rat

  2009cited by this paper
• Oxaliplatin‐induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia

  2009influential reference
• A review on oxaliplatin-induced peripheral nerve damage.

  2008cited by this paper
• Neuropathic pain—Current concepts

  2008cited by this paper
• Oxaliplatin-related neurotoxicity: how and why?

  2006cited by this paper
• Ambroxol, a Nav1.8-preferring Na(+) channel blocker, effectively suppresses pain symptoms in animal models of chronic, neuropathic and inflammatory pain.

  2005cited by this paper
• The pathogenesis and management of painful diabetic neuropathy: a review

  2003cited by this paper
• Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain.

  2002cited by this paper
• Pharmacological characterisation of the spared nerve injury model of neuropathic pain

  2002cited by this paper
• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

  2001cited by this paper
• Physico-chemical and biological properties of ambroxol under irradiation

  2001cited by this paper
• The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

  2000cited by this paper
• Neuropathic pain: aetiology, symptoms, mechanisms, and management.

  1999cited by this paper
• Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide.

  1998cited by this paper
• The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study.

  1996cited by this paper
• Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis.

  1994cited by this paper
• Antioxidant properties of Ambroxol.

  1994cited by this paper
• Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain

  1994cited by this paper
• Pain therapy

  1990cited by this paper
• Noxious thermal input from the rat tail: Modulation by descending inhibitory influences

  1977cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• Synthetic analgesics; methadone isomers and derivatives.

  1950cited by this paper
• Theories of general anesthesia.

  1950cited by this paper

• The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: Comparative study with celecoxib.

  2023cites this paper
• A prospective study of myeloperoxidase levels in water immersion.

  2022cites this paper
• Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson's disease: An approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies.

  2022cites this paper
• Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain

  2021cites this paper
• Neurorestorative effects of sub-chronic administration of ambroxol in rodent model of Parkinson’s disease

  2019cites this paper
• Ambroxol modulates 6‐Hydroxydopamine‐induced temporal reduction in Glucocerebrosidase (GCase) enzymatic activity and Parkinson's disease symptoms

  2018cites this paper
• Ambroxol for the treatment of fibromyalgia: science or fiction?

  2017cites this paper
• Chemotherapeutic agents induce mitochondrial superoxide production and toxicity but do not alter respiration in skeletal muscle in vitro.

  2017cites this paper